


Ask a doctor about a prescription for DOLOTREN 50 mg GASTRO-RESISTANT TABLETS
Package Leaflet: Information for the Patient
Dolotren 50 mg Gastro-Resistant Tablets
diclofenac sodium
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
The active substance of Dolotren 50 mg is diclofenac sodium. Dolotren 50 mg belongs to a group of medicines called non-steroidal anti-inflammatory drugs.
Dolotren 50 mg is used for the symptomatic treatment of the following conditions:
Post-traumatic inflammation.
It is important that you use the smallest dose of Dolotren that relieves or controls your pain and do not take this medicine for longer than necessary to control your symptoms.
Do not take Dolotren 50 mg
Make sure your doctor knows before taking diclofenac:
Side effects can be minimized by using the lowest effective dose for the shortest possible time.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Dolotren 50 mg:
This risk is greater when high doses and prolonged treatments are used in patients with a history of peptic ulcer and in the elderly. In these cases, your doctor will consider the possibility of associating a stomach protective medication.
Tell your doctor:
Patients with Cardiovascular Problems
Medicines like Dolotren can be associated with a moderate increase in the risk of heart attacks (myocardial infarction) or strokes, especially when used in high doses and prolonged treatments. Do not exceed the recommended dose or treatment duration.
If you have heart problems, a history of strokes, or think you may be at risk of suffering from these conditions (for example, you have high blood pressure, diabetes, high cholesterol, or are a smoker), you should discuss this treatment with your doctor or pharmacist.
Similarly, this type of medicine can cause fluid retention, especially in patients with heart disease and/or high blood pressure (hypertension).
Children and Adolescents
The use of Dolotren 50 mg is not recommended in children and adolescents under 14 years of age.
Elderly Patients
Elderly patients may be more sensitive to the effects of Dolotren 50 mg than the rest of adults. Therefore, it is especially important that elderly patients immediately inform their doctor of any adverse reactions that occur.
Other Medicines and Dolotren 50 mg
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Certain medicines can interfere with Dolotren, in which case it may be necessary to change the dose or interrupt treatment with one of them.
It is important that you inform your doctor if you are taking or have recently taken any of the following medicines:
Taking Dolotren with Alcohol
Do not drink alcohol while taking this medicine, as it may increase the toxicity of Dolotren.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Because the administration of medicines like Dolotren has been associated with an increased risk of congenital anomalies/abortions, it is not recommended during the first and second trimester of pregnancy unless strictly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time.
From the 20th week of pregnancy, Dolotren may cause kidney problems in your fetus if taken for more than a few days, which can lead to low levels of amniotic fluid surrounding the baby (oligohydramnios). If you need treatment during a period longer than a few days, your doctor may recommend additional checks.
In the third trimester, the administration of Dolotren is contraindicated, as it may harm your fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your tendency and that of your baby to bleed and delay or prolong delivery more than expected.
Breastfeeding
Ask your doctor or pharmacist for advice before taking any medicine.
Small amounts of Dolotren 50 mg may appear in breast milk, so you should not take Dolotren 50 mg if you are breastfeeding.
Fertility
For female patients of childbearing age, it should be noted that medicines like Dolotren have been associated with a decrease in fertility.
Driving and Using Machines
If you notice symptoms of drowsiness, dizziness, nausea, vision disorders, or other symptoms that alter your ability to concentrate, avoid performing tasks that require special attention (driving vehicles or operating machinery) until you know how you tolerate the medicine.
Dolotren 50 mg contains sodium (from potato carboxymethyl starch and diclofenac sodium)
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free").
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The tablets should be swallowed whole with a glass of water or other liquid, without dividing or chewing them. It is recommended to take them before meals. Your doctor will indicate the dose you should take, according to your disease.
The dose must be adjusted according to the patient's response. For each patient, it may be necessary to use other presentations containing the same active substance that better adjust to individual needs.
The recommended dose in mild cases or in prolonged treatments is 75-100 mg of diclofenac per day (one tablet twice a day).
As a general rule, the maximum recommended daily dose is 100-150 mg (2 or 3 tablets). Do not exceed the dose of 150 mg per day (3 tablets).
In menstrual pain, the daily dose, which should be individually adjusted, is 50-200 mg.
If you take more Dolotren 50 mg than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service immediately. Telephone: 91 562 04 20, indicating the medicine and the amount taken. It is recommended to carry the package and the leaflet of the medicine to the healthcare professional.
If you forget to take Dolotren 50 mg
Do not take a double dose to make up for forgotten doses.
If you forget a dose, take it as soon as you can, except if it is almost time for the next dose; then return to the usual administration schedule. If you forget several doses, consult your doctor.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Some adverse effects can be serious.
Stop using Dolotren 50 mg tablets and immediately inform your doctor if you experience any of the following serious adverse effects; you may need urgent medical treatment:
The observed adverse effects are described below according to their frequency of occurrence:
Very common (occurring in at least 1 in 10 patients), common (occurring in 1 to 10 in 100 patients), uncommon (occurring in 1 to 10 in 1,000 patients), rare (occurring in 1 to 10 in 10,000 patients), very rare (occurring in less than 1 patient in 10,000 patients), and of unknown frequency (cannot be estimated from available data).
Common adverse effects (occurring in 1 to 10 in 100 patients) are:
Stomach pain, nausea, vomiting, diarrhea, abdominal pain, difficult digestion (dyspepsia), flatulence (gas), loss of appetite, headache, dizziness, vertigo, skin rashes, increased serum transaminases.
Rare (occurring in 1 to 10 in 10,000 patients) or very rare (occurring in less than 1 patient in 10,000 patients) or of unknown frequency (cannot be estimated from available data) adverse effects are:
Gastrointestinal disorders
Rare adverse effects that occur with medicines like Dolotren are: gastritis (inflammation of the gastric mucosa), peptic ulcers, gastrointestinal bleeding, perforations (in some cases fatal), especially in the elderly, hematemesis (blood in vomit), melena (blood in stools), hemorrhagic diarrhea. Very rarely, the following have also been observed: colitis, worsening of ulcerative colitis and Crohn's disease, stomatitis (inflammation of the oral mucosa), glossitis (inflammation of the tongue), esophageal disorders, constipation, oral thrush, pancreatitis (inflammation of the pancreas), stenosis (intestinal narrowing).
Central nervous system disorders
Somnolence, disorientation, difficulty sleeping (insomnia), nightmares, irritability, convulsions, depression, anxiety, tremors, psychotic reactions, aseptic meningitis.
Cardiovascular disorders
Medicines like Dolotren may be associated with a moderate increase in the risk of suffering a heart attack ("myocardial infarction") or stroke.
Edema (fluid retention), hypertension, and heart failure have also been observed in association with treatments with medicines of the Dolotren type.
Skin and subcutaneous tissue disorders
Urticaria, severe skin reactions, increased sensitivity of the skin to sunlight, bleeding. Medicines like Dolotren may be associated, in very rare cases, with very serious skin reactions that present with blister formation, such as Stevens-Johnson syndrome and toxic epidermal necrolysis.
With unknown frequency: allergic skin reaction, which can include round or oval patches of redness and skin swelling, blisters, and itching (fixed drug eruption). There may also be darkening of the skin in the affected areas, which could persist after healing. The fixed drug eruption usually reappears in the same or the same sites if the medicine is taken again.
Hepatic disorders
Medicines like Dolotren may be associated, in rare cases, with hepatic disorders that cause yellowing of the skin and eyes (signs of hepatitis/liver failure), sometimes with high fever or swelling and sensitivity of the upper abdomen.
Interrupt treatment and inform your doctor IMMEDIATELY if any of the following reactions occur: yellowing of the skin or eyes.
Disorders of the senses
Visual disturbances (blurred or double vision), hearing problems, ringing in the ears, taste alterations.
Blood disorders
Symptoms of serious alterations of blood cells.
Renal disorders
In very rare cases, renal function anomalies have been observed that cause swelling of the face, feet, or legs, sudden decrease in urine output, bloody urine.
Hypersensitivity
Allergic reactions such as asthma and difficulty breathing or fainting.
Others
Numbness in the limbs, persistent sore throat, and high fever.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es/. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
No special storage conditions are required.
Do not use Dolotren 50 mg after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Dolotren 50 mg gastro-resistant tablets
Appearance of the Product and Packaging Content
Each package contains 20 or 40 coated yellow tablets, distributed in 2 or 4 PVC/Al blisters with 10 tablets each.
Not all package sizes may be marketed.
Marketing Authorization Holder
Faes Farma, S.A.
Autonomia Etorbidea, 10
48940 Leioa (Bizkaia)
Spain
Manufacturer
Faes Farma, S.A.
Maximo Agirre Kalea, 14
48940 Leioa (Bizkaia)
Spain
Date of the Last Revision of this Prospectus: July 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS):http://www.aemps.gob.es/
The average price of DOLOTREN 50 mg GASTRO-RESISTANT TABLETS in October, 2025 is around 1.65 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DOLOTREN 50 mg GASTRO-RESISTANT TABLETS – subject to medical assessment and local rules.